InvestorsHub Logo
Followers 0
Posts 1283
Boards Moderated 0
Alias Born 07/28/2019

Re: None

Tuesday, 03/24/2020 8:33:31 PM

Tuesday, March 24, 2020 8:33:31 PM

Post# of 18220
Nobody has mentioned This oncology asset “Company anticipates submitting a request in April for a Type C meeting with the FDA to discuss the phase III clinical program for ITX401 treatment of pancreatic cancer.”